PBX1 and breast cancer: To test this hypothesis we performed meta-analysis on METABRIC (Illumina arrays) and The Cancer Genome Atlas (TCGA, RNA-seq data) studies stratifying ERα-positive breast cancer patients in high and low PBX1 expressors.